reference/2706100

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2706100

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	4680
issn	0022-538X 1098-5514
issueIdentifier	8
pageRange	4676-4680
publicationName	Journal of Virology
startingPage	4676
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d9b2d67f9eec8901eca1c6493113db24 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d892b1c0ab0b16681710c2cc08057cf0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_762abc3cac6dd757580b9858b695517c
bibliographicCitation	Goujon C, Greenbury RA, Papaioannou S, Doyle T, Malim MH. A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2. J Virol. 2015 Apr;89(8):4676–80. PMID: 25673704; PMCID: PMC4442396.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad8534323f77c449030c10ec3eb2405e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8571-1108 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c74267d7a32af4a79dd5d24a4b424d4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ba36b7c653f3143811b2910d9f13cbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51da36683e07ed951f6b4dc797d1dfd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5b867a578551ad4dcb383b1f8b37bfd
date	2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1128/jvi.00169-15 https://pubmed.ncbi.nlm.nih.gov/PMC4442396 https://pubmed.ncbi.nlm.nih.gov/25673704
isPartOf	https://portal.issn.org/resource/ISSN/1098-5514 https://portal.issn.org/resource/ISSN/0022-538X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5334
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Triple-Arginine Motif in the Amino-Terminal Domain and Oligomerization Are Required for HIV-1 Inhibition by Human MX2
discusses	http://id.nlm.nih.gov/mesh/M0449454 http://id.nlm.nih.gov/mesh/M0128995 http://id.nlm.nih.gov/mesh/M0001683
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015497Q000378 http://id.nlm.nih.gov/mesh/D064547Q000235 http://id.nlm.nih.gov/mesh/D064547Q000378 http://id.nlm.nih.gov/mesh/D020816Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D058105 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D015151 http://id.nlm.nih.gov/mesh/D019084 http://id.nlm.nih.gov/mesh/D008969 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001120Q000235

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4600

Total number of triples: 47.